July 24, 2016 8:02 AM ET

Biotechnology

Company Overview of DBV Technologies S.A.

Executive Profile

Paul-Henri Lambert M.D.

Member of the Scientific Advisory Board, DBV Technologies S.A.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Prof. Paul-Henri Lambert, M.D., serves as the Chairman of Scientific Advisory Board at GlycoVaxyn AG. Prof. Lambert serves as a Member of Scientific Advisory Board at DBV Technologies. He serves as Chairman for the Global Advisory Committee for Vaccine Safety (GACVS) at the World Health Organisation (WHO). From 2000 to 2004, Prof. Lambert was Coordinator of the European Commission's European project on the Improvement of Neonatal Vaccination and was the Chairman of the ...

Corporate Headquarters

177-181 avenue Pierre Brossolette
Montrouge, Ile-de-France 92120

France

Phone: 33 1 55 42 78 78
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Université de Liège

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Carlos V. Paya M.D., Ph.D.Chief Executive Officer, President and Director
Immune Design Corp.
$530.5K
Werner Cautreels Ph.D.Chief Executive Officer, President and Director
Selecta Biosciences, Inc.
$400.0K
Stephen George Dilly M.B.B.S, Ph.D.Chief Executive Officer, President and Director
Aimmune Therapeutics, Inc.
$372.9K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DBV Technologies S.A., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.